pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,130 catalysts · 3,288 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: earnings×from 2026-03-02×clear all
type
  • 8k filing3,288
  • grant1,096
  • device adverse event1,000
  • earnings580
  • approval550
  • device 510k430
device pma
248
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area

    no tagged catalysts yet

    Week of Mar 2, 2026

    50
    ›Mar 2, 2026approval165d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Mar 2, 2026approval165d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Mar 2, 2026approval165d agoVENOFER (IRON SUCROSE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: AM REGENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 2, 2026approval165d agoIMODIUM MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE) — FDA approvalBionpharma Inc

    Sponsor: KENVUE BRANDS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 2, 2026approval165d agoOXCARBAZEPINE — FDA approvalOXCARBAZEPINE

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›Mar 2, 2026approval165d agoRIVAROXABAN — FDA approvalRIVAROXABAN

    Sponsor: APOTEX. Form: FOR SUSPENSION. Route: ORAL

    full page →RIVAROXABAN →fda approvals ↗
    ›Mar 2, 2026approval165d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 2, 2026approval165d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAVENOUS

    full page →SODIUM ACETATE →fda approvals ↗
    ›Mar 2, 2026approval165d agoMOXIFLOXACIN HYDROCHLORIDE — FDA approvalMOXIFLOXACIN HYDROCHLORIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →MOXIFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Mar 2, 2026approval165d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: PF PRISM CV. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 2, 2026earnings165d agoSMITH & NEPHEW PLC earningsSMITH & NEPHEW PLC

    Anticipated earnings call for SMITH & NEPHEW PLC ($SNN).

    full page →yahoo earnings ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: NATCO PHARMA LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: PH HEALTH. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoFLUTICASONE PROPIONATE — FDA approvalFougera Pharmaceuticals Inc

    Sponsor: GLENMARK SPECLT. Form: AEROSOL, METERED. Route: INHALATION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoTRACLEER (BOSENTAN) — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: ACTELION. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalACS Dobfar SpA

    Sponsor: ISTITUTO BIO ITA SPA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoBOSENTAN — FDA approvalBOSENTAN

    Sponsor: NATCO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →BOSENTAN →fda approvals ↗
    ›Mar 3, 2026approval164d agoLETROZOLE — FDA approvalYiling Pharmaceutical Ltd

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoLETROZOLE — FDA approvalYiling Pharmaceutical Ltd

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 3, 2026approval164d agoTRACLEER (BOSENTAN) — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: ACTELION. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 4, 2026approval163d agoBAL (DIMERCAPROL) — FDA approvalAkorn Operating Company LLC (Inactive)

    Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 4, 2026approval163d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

    Sponsor: ASPIRO. Form: INJECTABLE. Route: INJECTION

    full page →ROCURONIUM BROMIDE →fda approvals ↗
    ›Mar 4, 2026approval163d agoEMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE) — FDA approvalHetero USA Inc

    Sponsor: LAURUS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 4, 2026approval163d agoCALCITONIN-SALMON (CALCITONIN SALMON) — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 4, 2026approval163d agoDESIPRAMINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 4, 2026approval163d agoGLIPIZIDE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalPrinston Pharmaceutical Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoCHOLESTYRAMINE — FDA approvalCHOLESTYRAMINE

    Sponsor: MICRO LABS. Form: POWDER. Route: ORAL

    full page →CHOLESTYRAMINE →fda approvals ↗
    ›Mar 5, 2026approval162d agoIBUPROFEN — FDA approvalMidol

    Sponsor: RUBICON RESEARCH. Form: SUSPENSION. Route: ORAL

    full page →Midol →fda approvals ↗
    ›Mar 5, 2026approval162d agoTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalteclistamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →teclistamab →fda approvals ↗
    ›Mar 5, 2026approval162d agoTALVEY (TALQUETAMAB-TGVS) — FDA approvaltalquetamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →talquetamab →fda approvals ↗
    ›Mar 5, 2026approval162d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: ANTHEA PHARMA. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoAPREPITANT — FDA approvalAPREPITANT

    Sponsor: MYLAN. Form: EMULSION. Route: INTRAVENOUS

    full page →APREPITANT →fda approvals ↗
    ›Mar 5, 2026approval162d agoCHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE) — FDA approvalAlgoTherapeutix SAS

    Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoCHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE) — FDA approvalAlgoTherapeutix SAS

    Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoXYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approvalSanofi

    Sponsor: CHATTEM SANOFI. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoKEFLEX (CEPHALEXIN) — FDA approvalBelcher Pharmaceuticals LLC

    Sponsor: PRAGMA. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval162d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ← prev
    page 1 of 23
    next →
    $AMRX17.27-2.21%
    $NSRX2.7000-1.82%
    $SNN30.11+0.90%
    $AMRX17.27-2.21%
    $AMRX17.27-2.21%
    $NSRX2.7000-1.82%
    $TEVA36.52-0.60%
    $SNY43.78+0.16%